Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.69 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.69 |
| ▸ | SRC | P12931 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.69 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.69 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.69 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.67 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.67 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.67 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.66 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.66 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.66 |
| ▸ | LDHA | P00338 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | FBP1 | P09467 | 1/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.66 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4945718 | 1.00 | P2RY1 (0.69) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL30903856 | 0.93 | P2RY1 (0.68) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL347342 | 0.93 | P2RY1 (0.68) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL17148064 | 0.92 | P2RY1 (0.67) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Phosphate SCHEMBL15671063 | 0.91 | P2RY1 (0.76) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL18423487 | 0.89 | P2RY1 (0.73) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Triphosphate SCHEMBL3515197 | 0.88 | P2RY1 (0.70) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL21067651 | 0.86 | P2RY1 (0.60) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| SCHEMBL27695784 | 0.86 | P2RY1 (0.63) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Phosphate SCHEMBL1050410 | 0.86 | P2RY1 (0.76) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570688-B2 | Activated cysteine-directed polypeptide ligation technique | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2026-03-10 | — | — | US | disclosed |
| US-20230002442-A1 | AN ACTIVATED CYSTEINE-DIRECTED POLYPEPTIDE LIGATION TECHNIQUE | THE TEXAS A&M UNIVERSITY SYSTEM | 2023-01-05 | — | — | US | disclosed |
| EP-4085139-A1 | AN ACTIVATED CYSTEINE-DIRECTED POLYPEPTIDE LIGATION TECHNIQUE | The Texas A&M University System (US) | 2022-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570688-B2 | Activated cysteine-directed polypeptide ligation technique | PTMS, LNPEP, ANPEP | P2RY1 4101/4885P2RY2 3502/4885SRC 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.